MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511126370 A) filed by Swami Rama Himalayan University, Dehradun, Uttarakhand, on Dec. 13, 2025, for 'a system for cell-free biomanufacturing and formulation of biopolymeric therapeutics.'
Inventor(s) include Arvind Singh Farswan; Sumit Joshi; Ritu Sanwal; and Srishti Dora.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a system for cell-free biomanufacturing and formulation of biopolymeric therapeutics, wherein a cell-free protein synthesis (CFPS) module incorporating a reaction vessel is configured to synthesize an active biopolymeric molecule from a gene sequence using cell lysates, substrates, nucleotides, and an energy regenerating system under controlled temperature, pH, and mechanical stress. The system further comprises a downstream purification module employing chromatography techniques to separate the active molecule from synthesis by-products, and a formulation module that combines the purified molecule with polymeric excipients and absorption enhancers into a pharmaceutical dosage form. A regulatory and quality control interface continuously monitors process parameters and performs analytical assessments, including bioassays, potency tests, and immunogenicity assays, thus ensuring reliable production of therapeutic biopolymers."
Disclaimer: Curated by HT Syndication.
